Loading...

NDRA ENDRA LIFE SCIENCES INC Capital Structure Changes 8-K Filing

NDR

NDR

ENDRA LIFE SCIENCES INC

(NDRA)

2024 8-K

Show Summary

Show Summary

Investor Meetings

Failure to Maintain Listing...

Financial Statements

Financial Results

Nasdaq Compliance

Financial Results

Stock Split Approval

Nasdaq Compliance Extension

CEO Resignation

Management Changes

Agreement for Stock and War...

Financial Results Announcement

Results of Operations and F...

Financial Results Announcement

Financial Results Announcement

Financial Results and FDA A...

Annual Meeting Results

Meeting Adjournment

Financial Results Announcement

Underwriting Agreement

Financial Results

Financial Results Announcement

External Links:

ENDRA Life Sciences Inc. approved a reverse stock split at a ratio of 1/35, effective November 7, 2024, changing the trading of its common stock to a split-adjusted basis.

AI Assistant

ENDRA LIFE SCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.